Annovera 17.4 mg/1
segesterone acetate and ethinyl estradiol · RING · Mayne Pharma
Annovera is a ring containing segesterone acetate and ethinyl estradiol at 17.4 mg/1, taken vaginal. Manufactured by Mayne Pharma.
Key Facts
- Brand Name
- Annovera
- Generic Name
- segesterone acetate and ethinyl estradiol
- NDC Code (Product)
68308-752- Manufacturer
- Mayne Pharma
- Strength
- 17.4 mg/1
- Dosage Form
- RING
- Route
- VAGINAL
- Marketing Status
- Application #
- NDA209627
- Drug Class
- Estrogen [EPC]
- Marketing Start
- 08/16/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is Annovera used for?
Annovera contains segesterone acetate and ethinyl estradiol. It is a ring taken vaginal. Consult your doctor for specific uses.
Is Annovera a controlled substance?
Annovera is not classified as a controlled substance by the DEA.
What is the generic name for Annovera?
The generic name for Annovera is segesterone acetate and ethinyl estradiol. There are no other listed brand versions of segesterone acetate and ethinyl estradiol.
What is the NDC code for Annovera 17.4 mg/1?
The NDC (National Drug Code) for Annovera 17.4 mg/1 is 68308-752, listed by Mayne Pharma.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)